NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-230-2012-0-NL-76 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 NL EP 19212016.0 Issued
NCI E-230-2012-0-DK-72 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 DK EP 19212016.0 Issued
NCI E-230-2012-0-NO-77 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 NO EP 19212016.0 Issued
NCI E-230-2012-0-SE-79 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 SE EP 19212016.0 Issued
NCI E-230-2012-0-ES-78 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 ES EP 19212016.0 Issued
NCI E-230-2012-0-FR-73 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 FR EP 19212016.0 Issued
NCI E-230-2012-0-DE-74 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 DE EP 19212016.0 Issued
NCI E-230-2012-0-IT-75 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 IT EP 19212016.0 Issued
NCI E-230-2012-0-EP-17 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 EP DIV 19212016.0 Issued
NCI E-230-2012-0-CH-80 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 CH EP 19212016.0 Issued
NCI E-230-2012-0-GB-81 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 GB EP 19212016.0 Issued
NCI E-230-2012-0-BE-71 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 BE EP 19212016.0 Issued
NCI E-269-2010-0-IL-26 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IL DIV 2021-10-27 Issued
NCI E-127-2018-0-PCT-02 Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy PCT PCT PCT/US2019/063761 Expired
NCI E-065-2015-0-US-07 GRIFFITHSIN MUTANTS US CON 16/697,685 Pending
NCI E-127-2018-0-US-03 Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy US ORD 16/698,186 Pending
NCI E-205-2010-1-US-03 PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES US CON 16/695,674 11364298 Issued PDF
NHLBI E-149-2018-0-PCT-02 Use Of VDAC Inhibitor VBIT 4 In Lupus Treatment PCT PCT PCT/IL2019/051290 Expired
NHLBI E-149-2018-0-EP-04 Use Of VDAC Inhibitor VBIT 4 In Lupus Treatment EP National Stage 19888509.7 Abandoned
NHLBI E-149-2018-0-CN-05 Use Of VDAC Inhibitor VBIT 4 In Lupus Treatment CN National Stage 201980090212.4 Pending
NHLBI E-149-2018-0-IL-06 Use Of VDAC Inhibitor VBIT 4 In Lupus Treatment IL National Stage 283443 Pending
NIBIB E-062-2017-0-US-07 SYSTEMS AND METHODS FOR THREE- DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING US National Stage 16/616,891 11428632 Issued PDF
NCI E-205-2010-2-US-20 PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATESIDS US CON 16/694,761 11364297 Issued PDF
NIAID E-042-2018-0-US-07 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE US National Stage 16/616,873 11273214 Issued PDF
NIDCR E-152-2017-0-US-05 FORMATION OF STABLE CARTILAGE US National Stage 16/616,418 10940241 Issued PDF
NHLBI E-155-2016-0-US-03 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US CON 16/692,849 Abandoned
NLM E-107-2010-2-US-31 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/691,255 Abandoned
NLM E-107-2010-2-US-30 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/691,247 Abandoned
NEI E-015-2019-0-CN-04 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CN National Stage 201980076370.4 Issued
NCI E-065-2017-0-US-06 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY US National Stage 16/614,652 11389480 Issued PDF
NEI E-015-2019-0-PCT-01 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE PCT PCT COMB PCT/US2019/062016 Expired
NCI E-257-2014-0-US-04 IMMUNOGENIC MODULATION BY ENDOCRINE DEPRIVATION THERAPY IMPROVES SENSITIVITY OF TUMOR CELLS TO IMMUNE MEDIATED LYSIS US DIV 16/686,390 Abandoned
NEI E-015-2019-0-EP-06 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE EP National Stage 19832222.4 Pending
NEI E-015-2019-0-JP-08 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE JP National Stage 2021-527104 Pending
NEI E-015-2019-0-JP-09 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE JP DIV
NEI E-015-2019-0-KR-09 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE KR National Stage 10-2021-7018798 Pending
NEI E-015-2019-0-SG-10 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE SG National Stage 11202104401R Pending
NEI E-015-2019-0-IL-07 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE IL National Stage 282791 Pending
NEI E-015-2019-0-CA-03 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CA National Stage 3119041 Pending
NEI E-015-2019-0-AU-02 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE AU National Stage 2019385332 Pending
NCI E-106-2017-0-US-03 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS US National Stage 16/613,971 11390683 Issued PDF
NCI E-040-2012-0-US-44 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US DIV 16/684,978 10837019 Issued PDF
NCI E-040-2012-0-US-45 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US DIV 16/684,994 10829769 Issued PDF
NCI E-040-2012-0-US-43 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US DIV 16/684,962 10829768 Issued PDF
NCI E-494-2013-0-EP-10 Methods of Preparing Anti-human Papillomavirus Antigen T Cells EP DIV 19209253.4 Issued
NCI E-494-2013-0-ES-35 Methods of Preparing Anti-human Papillomavirus Antigen T Cells ES EP 19209253.4 Issued
NCI E-494-2013-0-NL-34 Methods of Preparing Anti-human Papillomavirus Antigen T Cells NL EP 19209253.4 Issued
NCI E-494-2013-0-GB-36 Methods of Preparing Anti-human Papillomavirus Antigen T Cells GB EP 19209253.4 Issued
NCI E-494-2013-0-DE-32 Methods of Preparing Anti-human Papillomavirus Antigen T Cells DE EP 19209253.4 Issued
NCI E-494-2013-0-FR-31 Methods of Preparing Anti-human Papillomavirus Antigen T Cells FR EP 19209253.4 Issued